Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Reksa Dana Indeks SAM ETF SRI-KEHATI (XSSK)

Organon Pharma Indonesia Tbk.Trading

Reksa Dana Indeks SAM ETF SRI-KEHATITrading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Organon Pharma Indonesia Tbk. dan Reksa Dana Indeks SAM ETF SRI-KEHATI: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Reksa Dana Indeks SAM ETF SRI-KEHATI diperdagangkan di Rp615 (kapitalisasi pasar 11,01 M). Perbedaan utamanya: Organon Pharma Indonesia Tbk. jauh lebih besar — sekitar 9,5× kapitalisasi pasar Reksa Dana Indeks SAM ETF SRI-KEHATI. Mana yang lebih baik tergantung tujuan investasimu.

	SCPI	XSSK
Kapitalisasi Pasar	104,4 M	11,01 M

Lihat detail →Lihat detail →

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

SCPI

Lihat detail →

XSSK

Lihat detail →

Tentang Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Selengkapnya di halaman SCPI →